학술논문
A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial
Document Type
Article
Author
Peters, Solange; Danson, Sarah; Hasan, Baktiar; Dafni, Urania; Reinmuth, Niels; Majem, Margarita; Tournoy, Kurt G.; Mark, Michael T.; Pless, Miklos; Cobo, Manuel; Rodriguez-Abreu, Delvys; Falchero, Lionel; Moran, Teresa; Ortega Granados, Ana Laura; Monnet, Isabelle; Mohorcic, Katja; Sureda, Bartomeu Massutí; Betticher, Daniel; Demedts, Ingel; Macias, Jose Antionio; Cuffe, Sinead; Luciani, Andrea; Sanchez, Jose Garcia; Curioni-Fontecedro, Alessandra; Gautschi, Oliver; Price, Gillian; Coate, Linda; von Moos, Roger; Zielinski, Christoph; Provencio, Mariano; Menis, Jessica; Ruepp, Barbara; Pochesci, Alessia; Roschitzki-Voser, Heidi; Besse, Benjamin; Rabaglio, Manuela; O’Brien, Mary E.R.; Stahel, Rolf A.
Source
In Journal of Thoracic Oncology October 2020 15(10):1647-1656
Subject
Language
ISSN
1556-0864